M. Furey

发表

Distributed and Overlapping Representations of Faces and Objects in Ventral Temporal Cortex

A. Ishai, J. Haxby, P. Pietrini, 2001, Science.

Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease

G. Alexander, P. Pietrini, M. Furey, 1998, Neurology.

Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression

M. Furey, J. Price, W. Drevets, 2008, Brain Structure and Function.

The prominent role of stimulus processing: cholinergic function and dysfunction in cognition.

M. Furey, 2011, Current opinion in neurology.

Distinct, overlapping representations of faces and multiple categories of objects in ventral temporal cortex

A. Ishai, J. Haxby, P. Pietrini, 2001, NeuroImage.

Cholinergic enhancement and increased selectivity of perceptual processing during working memory.

J. Haxby, P. Pietrini, M. Furey, 2000, Science.

Cholinergic enhancement improves performance on working memory by modulating the functional activity in distinct brain regions: a positron emission tomography regional cerebral blood flow study in healthy humans

G. Alexander, P. Pietrini, M. Furey, 2000, Brain Research Bulletin.

Altered brain functional connectivity and impaired short-term memory in Alzheimer's disease.

P. Pietrini, C. Grady, M. Furey, 2001, Brain : a journal of neurology.

BrainSeq: Neurogenomics to Drive Novel Target Discovery for Neuropsychiatric Disorders

Brian J. Eastwood, Andrew E. Jaffe, Daniel R. Weinberger, 2015, Neuron.

Association between subcortical volumes and verbal memory in unmedicated depressed patients and healthy controls

M. Furey, W. Drevets, A. Nugent, 2012, Neuropsychologia.

Dissociation of face-selective cortical responses by attention.

J. Haxby, R. Hari, M. Furey, 2006, Proceedings of the National Academy of Sciences of the United States of America.

Synaptic Potentiation Is Critical for Rapid Antidepressant Response to Ketamine in Treatment-Resistant Major Depression

C. Grillon, M. Furey, C. Zarate, 2012, Biological Psychiatry.

Cholinergic stimulation alters performance and task-specific regional cerebral blood flow during working memory.

J. Haxby, G. Alexander, J. VanMeter, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Individual differences in PET activation of object perception and attention systems predict face matching accuracy.

J R Moeller, J D Van Horn, P Pietrini, 1999, Neuroreport.

Abnormal brain glucose metabolism in the delusional misidentification syndromes: A positron emission tomography study in Alzheimer disease

Gene E. Alexander, Pietro Pietrini, Barry Horwitz, 1995, Biological Psychiatry.

Altered connectivity among emotion-related brain regions during short-term memory in Alzheimer's disease

Cheryl L. Grady, Barry Horwitz, Maura L. Furey, 2010, Neurobiology of Aging.

Potential of pretreatment neural activity in the visual cortex during emotional processing to predict treatment response to scopolamine in major depressive disorder.

M. Furey, W. Drevets, C. Zarate, 2013, JAMA psychiatry.

Pretreatment Differences in BOLD Response to Emotional Faces Correlate with Antidepressant Response to Scopolamine

M. Furey, W. Drevets, A. Nugent, 2015, The international journal of neuropsychopharmacology.

Baseline working memory activation deficits in dimensional anxious depression as detected by magnetoencephalography

M. Furey, D. Luckenbaugh, A. Nugent, 2015, Acta Neuropsychiatrica.

Neurophysiological Changes Associated with Antidepressant Response to Ketamine Not Observed in a Negative Trial of Scopolamine in Major Depressive Disorder

M. Furey, A. Nugent, C. Zarate, 2018, The international journal of neuropsychopharmacology.

Brain cognition and metabolism in Down syndrome adults in association with development of dementia

P Pietrini, B Horwitz, G. Alexander, 1996, Neuroreport.

Relationship Between Dissociation and Antidepressant Effects of Esketamine Nasal Spray in Patients With Treatment-Resistant Depression

Xiang Li, M. Furey, W. Drevets, 2022, The international journal of neuropsychopharmacology.

In vivo evaluation of the effect of stimulus distribution on FIR statistical efficiency in event-related fMRI

M. Furey, J. Duyn, W. Drevets, 2013, Journal of Neuroscience Methods.

Neural Activity in Ventral Extrastriate Cortex during Tactile Discrimination of Faces and Other Objects in Congenitally Blind and Sighted Subjects. Presented at the 8th International Conference on Functional Mapping of Human Brain Mapping, June 2-6, 2002 Sendai, Japan. NeuroImage 658

J. Haxby, M. Guazzelli, L. Cohen, 2002 .

Functional anatomy of autobiographical memory recall deficits in depression

Kymberly D. Young, S. Fromm, M. Furey, 2011, Psychological Medicine.

Cholinergic Modulation Enhances Visual Processing During Working Memory

M. L. Furey, P. Pietrini, S. M. Courtney, 1998, NeuroImage.

Clinical pharmacokinetics, pharmacodynamics, safety, and tolerability of JNJ-54175446, a brain permeable P2X7 antagonist, in a randomised single-ascending dose study in healthy participants

M. Furey, G. Triana-Baltzer, A. Bhattacharya, 2018, Journal of psychopharmacology.

Ketamine normalizes brain activity during emotionally valenced attentional processing in depression

Jennifer W. Evans, M. Furey, A. Nugent, 2018, NeuroImage: Clinical.

Changes in the neural correlates of implicit emotional face processing during antidepressant treatment in major depressive disorder.

Teresa A. Victor, S. Fromm, M. Furey, 2013, The international journal of neuropsychopharmacology.

Neural basis of abnormal response to negative feedback in unmedicated mood disorders

Guy B. Williams, Barbara J. Sahakian, Maura L. Furey, 2008, NeuroImage.

Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial.

M. Furey, W. Drevets, 2006, Archives of general psychiatry.

Antidepressant Efficacy of the Antimuscarinic Drug Scopolamine

M. Furey, W. Drevets, 2006 .

Beyond sensory images: Object-based representation in the human ventral pathway.

Emiliano Ricciardi, Pietro Pietrini, Leonardo Cohen, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Effects of Ketamine on Brain Activity During Emotional Processing: Differential Findings in Depressed Versus Healthy Control Participants.

Jennifer W. Evans, M. Furey, A. Nugent, 2019, Biological psychiatry. Cognitive neuroscience and neuroimaging.

Cholinergic enhancement reduces functional connectivity and BOLD variability in visual extrastriate cortex during selective attention

Emiliano Ricciardi, Pietro Pietrini, Giacomo Handjaras, 2013, Neuropharmacology.

Cholinergic modulation of visual working memory during aging: A parametric PET study

Emiliano Ricciardi, Pietro Pietrini, Maura L. Furey, 2009, Brain Research Bulletin.

Cholinergic Enhancement Eliminates Modulation of Neural Activity by Task Difficulty in the Prefrontal Cortex during Working Memory

Emiliano Ricciardi, Pietro Pietrini, Maura L. Furey, 2008, Journal of Cognitive Neuroscience.

Selective Effects of Cholinergic Modulation on Task Performance during Selective Attention

Pietro Pietrini, James V Haxby, Maura L Furey, 2008, Neuropsychopharmacology.

Replication of Scopolamine's Antidepressant Efficacy in Major Depressive Disorder: A Randomized, Placebo-Controlled Clinical Trial

M. Furey, W. Drevets, 2010, Biological Psychiatry.

Antidepressant Effects of the Muscarinic Receptor Antagonist Scopolamine: Clinical and Preclinical Review

M. Furey, W. Drevets, A. Bhattacharya, 2021, Contemporary Clinical Neuroscience.

The antidepressant efficacy of the muscarinic antagonist scopolamine: Past findings and future directions.

M. Furey, W. Drevets, A. Bhattacharya, 2020, Advances in pharmacology.

Amygdala response to explicit sad face stimuli at baseline predicts antidepressant treatment response to scopolamine in major depressive disorder

Allison C. Nugent, Maura L. Furey, Wayne C. Drevets, 2016, Psychiatry Research: Neuroimaging.

Antidepressant Effects of the Muscarinic Cholinergic Receptor Antagonist Scopolamine: A Review

M. Furey, W. Drevets, C. Zarate, 2013, Biological Psychiatry.

Scopolamine Produces Larger Antidepressant and Antianxiety Effects in Women Than in Men

M. Furey, W. Drevets, A. Khanna, 2010, Neuropsychopharmacology.

Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis.

P Pietrini, G. Alexander, P. Pietrini, 1997, The American journal of psychiatry.

Nocturnal Wakefulness Is Associated With Next-Day Suicidal Ideation in Major Depressive Disorder and Bipolar Disorder.

M. Furey, E. Ballard, D. Luckenbaugh, 2016, The Journal of clinical psychiatry.

Ketamine’s Antidepressant Efficacy is Extended for at Least Four Weeks in Subjects with a Family History of an Alcohol Use Disorder

M. Furey, E. Ballard, D. Luckenbaugh, 2014, The international journal of neuropsychopharmacology.

Cholinergic enhancement differentially modulates neural response to encoding during face identity and face location working memory tasks

Emiliano Ricciardi, Pietro Pietrini, Giacomo Handjaras, 2013, Experimental biology and medicine.

Effects of Mu-Opiate Receptor Gene Polymorphism rs1799971 (A118G) on the Antidepressant and Dissociation Responses in Esketamine Nasal Spray Clinical Trials

M. Furey, W. Drevets, D. Hibar, 2020, The international journal of neuropsychopharmacology.

Human Biomarkers of Rapid Antidepressant Effects

Maura L. Furey, Carlos A. Zarate, M. Furey, 2013, Biological Psychiatry.

Relationship between amygdala responses to masked faces and mood state and treatment in major depressive disorder.

Maura L Furey, Teresa A. Victor, S. Fromm, 2010, Archives of general psychiatry.

Translating depression biomarkers for improved targeted therapies

D. Bredt, M. Furey, W. Drevets, 2015, Neuroscience & Biobehavioral Reviews.

Functional brain studies of the neurometabolic bases of cognitive and behavioral changes in Alzheimer's disease

G. Alexander, M. Guazzelli, P. Pietrini, 2001 .

Cerebral metabolic response to passive audiovisual stimulation in patients with Alzheimer's disease and healthy volunteers assessed by PET.

P Pietrini, B Horwitz, G. Alexander, 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Increasing required neural response to expose abnormal brain function in mild versus moderate or severe Alzheimer's disease: PET study using parametric visual stimulation.

P Pietrini, G. Alexander, P. Pietrini, 1998, The American journal of psychiatry.

Biomarkers in mood disorders research: developing new and improved therapeutics.

M. Furey, A. Nugent, D. Ionescu, 2014, Revista de psiquiatria clinica.

Baseline mood-state measures as predictors of antidepressant response to scopolamine

M. Furey, W. Drevets, D. Luckenbaugh, 2012, Psychiatry Research.

Ketamine Alters Electrophysiological Responses to Emotional Faces in Major Depressive Disorder.

F. Carver, M. Furey, A. Nugent, 2020, Journal of affective disorders.

Altered interaction with environmental reinforcers in major depressive disorder: Relationship to anhedonia.

M. Furey, C. Lejuez, A. Nugent, 2017, Behaviour research and therapy.

Resting state brain glucose metabolism is not reduced in normotensive healthy men during aging, after correction for brain atrophy

Pietro Pietrini, Barry Horwitz, Vicente Ibáñez, 2004, Brain Research Bulletin.

The neurometabolic landscape of cognitive decline: in vivo studies with positron emission tomography in Alzheimer's disease.

G. Alexander, M. Guazzelli, P. Pietrini, 2000, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

Dissociable temporal effects of bupropion on behavioural measures of emotional and reward processing in depression

M. Furey, W. Drevets, C. Harmer, 2017, Philosophical Transactions of the Royal Society B: Biological Sciences.

Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety.

M. Furey, E. Ballard, D. Luckenbaugh, 2014, Journal of psychiatric research.

Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.

J V Haxby, P Pietrini, B Horwitz, 1997, The American journal of psychiatry.

Group differences in MEG-ICA derived resting state networks: Application to major depressive disorder

Richard Coppola, Stephen E. Robinson, Allison C. Nugent, 2015, NeuroImage.

Network analysis of PET-mapped visual pathways in Alzheimer type dementia.

J V Haxby, B Horwitz, J. Haxby, 1995, Neuroreport.

Neural Correlates of Suicidal Ideation and Its Reduction in Depression

M. Furey, E. Ballard, D. Luckenbaugh, 2015, The international journal of neuropsychopharmacology.

Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications.

P Pietrini, G. Alexander, P. Pietrini, 1996, The American journal of psychiatry.

Depression and the Brain

M. Furey, W. Drevets, 2009 .

Antidepressant treatment history as a predictor of response to scopolamine: clinical implications.

M. Furey, D. Luckenbaugh, C. Zarate, 2014, Journal of affective disorders.

The Extended Functional Neuroanatomy of Emotional Processing Biases for Masked Faces in Major Depressive Disorder

Maura L. Furey, Stephen J. Fromm, Wayne C. Drevets, 2012, PloS one.

DEVELOPING BIOMARKERS IN MOOD DISORDERS RESEARCH THROUGH THE USE OF RAPID‐ACTING ANTIDEPRESSANTS

M. Furey, A. Nugent, D. Ionescu, 2014, Depression and anxiety.

The effect of brain atrophy on cerebral hypometabolism in the visual variant of Alzheimer disease.

P Pietrini, B Horwitz, G. Alexander, 2001, Archives of neurology.

Riluzole likely lacks antidepressant efficacy in ketamine non-responders.

M. Furey, E. Ballard, D. Luckenbaugh, 2014, Journal of psychiatric research.

In vivo biochemistry of the brain in understanding human cognition and emotions: towards a molecular psychology

M. Guazzelli, P. Pietrini, M. Furey, 1999, Brain Research Bulletin.

Time Course of Pharmacodynamic and Pharmacokinetic Effects of Physostigmine Assessed by Functional Brain Imaging in Humans

P Pietrini, G. Alexander, P. Pietrini, 2000, Pharmacology Biochemistry and Behavior.

Pharmacological modulation of prefrontal cortical activity during a working memory task in young and older humans: a PET study with physostigmine.

Emiliano Ricciardi, Pietro Pietrini, Maura L Furey, 2005, The American journal of psychiatry.

Cerebral Metabolic Responses to Clomipramine Are Greatly Reduced Following Pretreatment with the Specific Serotonin Neurotoxin Para-Chloroamphetamine (PCA)

P. Pietrini, M. Furey, M. Dam, 1995, Neuropsychopharmacology.

Association between brain functional failure and dementia severity in Alzheimer's disease: resting versus stimulation PET study.

G. Alexander, M. Guazzelli, P. Pietrini, 1999, The American journal of psychiatry.

REGIONAL CEREBRAL GLUCOSE-METABOLISM AT REST AND DURING SENSORY STIMULATION IN PATIENTS WITH ALZHEIMERS-DISEASE

G. Alexander, P. Pietrini, C. Grady, 1995 .

Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression

M. Furey, J. Price, W. Drevets, 2008, Brain Structure and Function.

Relation of age and apolipoprotein E to cognitive function in Down syndrome adults

G. Alexander, P. Pietrini, M. Furey, 1997, Neuroreport.

Antidepressant Effects of the Muscarinic Cholinergic Receptor Antagonist Scopolamine: A Review

M. Furey, W. Drevets, C. Zarate, 2013, Biological Psychiatry.

Potential of pretreatment neural activity in the visual cortex during emotional processing to predict treatment response to scopolamine in major depressive disorder.

M. Furey, W. Drevets, C. Zarate, 2013, JAMA psychiatry.

Amygdala response to explicit sad face stimuli at baseline predicts antidepressant treatment response to scopolamine in major depressive disorder

M. Furey, W. Drevets, A. Nugent, 2016, Psychiatry Research: Neuroimaging.

Cerebral Metabolic Response to Passive Audiovisual Stimulation in Patients with Alzheimer â€˜sDisease and Healthy Volunteers Assessed by PET

M. Furey, M. Mentis, Barry Horwitz, 2006 .

In vivo evaluation of the effect of stimulus distribution on FIR statistical efficiency in event-related fMRI

M. Furey, J. Duyn, P. van Gelderen, 2013, Journal of Neuroscience Methods.

Pulsed intravenous administration of scopolamine produces rapid antidepressant effects and modest side effects.

M. Furey, C. Zarate, 2013, The Journal of clinical psychiatry.